Webinar: Leveraging Benefit Data to Improve the Point of Care Experience

Modest improvements to eligibility, formulary & benefit files can positively impact ePrescribing at the point of care and lead to cost savings. The purpose of the webinar is to highlight the importance of having complete eligibility, formulary and benefit data and showcase how this can enhance downstream transactions like real-time benefit check, electronic prior authorization, and specialty enrollment. The webinar will also cover the implementation of the new NCPDP version 5 Formulary & Benefit standard.

Scott Motejunas

Manager, Product Innovation

Surescripts

Scott Motejunas has a passion for helping innovative businesses define and execute their growth strategies. Within the Product Innovation team at Surescripts, he is responsible for driving new and existing products along the product lifecycle, and he currently focuses on solutions aimed at improving medication management for patients. Prior to Surescripts, he has held various healthcare strategy and investment roles, most recently working on the corporate strategy team at Humana, a leading Medicare Advantage plan. He received a BA from the Johns Hopkins University with Honors in Economics and an MBA from the Darden School of the University of Virginia.



Michael Burger

Senior Consultant, EHRs and EDI

Point-of-Care Partners

Michael Burger is a Senior Consultant at Point-of-Care Partners. Michael specializes in both clinical and administrative systems and processes. As a product development and business development leader, Michael has led various healthcare organizations through revenue cycle and electronic health record (EHR) implementation and optimization projects. He is specifically sought after for his expert knowledge of clinical and financial EDI, most notably resulting in testimony before the DEA and NCVHS regarding ePrescribing.

NOW AVAILABLE ON-DEMAND

© 2021 Questex LLC, All right reserved.

685 Third Avenue, 21st Floor New York, NY 10017

Reproduction in whole or part is prohibited.